February is Cancer Prevention Month, and oftentimes when we think about breast cancer, we think about females, but not males.
Wojcicki and New Mountain have offered to acquire all of 23andMe's outstanding shares in cash for $2.53 per share, or an ...
Discover the rise and dramatic fall of 23andMe, once a $6 billion genetics pioneer. From revolutionising consumer DNA testing to facing privacy breaches and market shifts, OxStu explores how trust, ...
More than two years after a quadruple homicide devastated Moscow, Idaho, a judge unsealed the transcript of a recent hearing ...
The new project will utilize AI to determine how methods used to analyze animal and plant genetic databases could benefit the ...
23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the company private. They are offering to buy all outstanding shares in cash for $2.53 per share, or an equity ...